Skip to main content
Clinical Trials/NCT04666337
NCT04666337CompletedNot Applicable

Fentanyl Versus Tramadol as Co-administrator to Bupivacaine in Ultrasound-guided Supraclavicular Brachial Plexus Blockade: Pons and Cons

Aswan University Hospital2 sites in 1 country66 target enrollmentStarted: February 15, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
66
Locations
2
Primary Endpoint
Onset time of sensory block in minutes

Study Overview

Brief Summary

Supraclavicular brachial plexus approach is an alternative technique to general anesthesia resulting in a fast onset of a reliable blockage of the brachial plexus. The use of ultrasound for the performance of supraclavicular block has become the gold standard since it enables the clinician to deposit the local anesthetic close to the nerves in real-time that improves the success rate with a safety margin. Adjuvants are added to local anesthetic in Supraclavicular Brachial Plexus Blockade to improve the quality of nerve blocks and the duration of analgesia. It should be noted that no adjuvant has been approved by the Food and Drug Administration (FDA) for the prolongation of peripheral nerve blocks

Detailed Description

There are multiple controversies among the previous studies for the use of different opioids as adjuvants for brachial plexus blockade to improve various block characteristics. Moreover, limited studies estimate the pons and cons of tramadol versus fentanyl as co-administrator to bupivacaine in Ultrasound-guided Supraclavicular Brachial Plexus Blockade.

In our study, we aim to assess the utility of fentanyl versus tramadol as co-administrator to bupivacaine in ultrasound-guided supraclavicular brachial plexus blockade in upper limb surgeries in a prospective randomized controlled fashion. The primary outcome is to compare between the efficacy of tramadol versus fentanyl as adjuvants on the onset and duration of sensory and motor block and the secondary outcome is to compare between the efficacy of tramadol versus fentanyl as adjuvants on postoperative analgesia, time of the request to rescue analgesia, postoperative analgesic consumption, and complications.

The patients were aged between 18 and 60, both gender, and the American Society of Anesthesiologists (ASA) physical status I/II. However, patients who had bleeding disorders got opioid analgesics or monoamine oxidase inhibitors before surgery, had a history of seizures, respiratory or cardiac diseases, local infections at the site where needle for the block is to be inserted, pregnant woman and in whom the block effect was partial and required supplementary anesthesia were excluded from the study.

Patients were randomly allocated into three groups for ultrasound-guided supraclavicular brachial plexus block. Randomization was established using the computer-generated closed envelopes method.

Group B (bupivacaine group): patients received 20 ml bupivacaine 0.5% plus 2 ml normal saline Group F (fentanyl group): patients received 20 ml bupivacaine 0.5% plus fentanyl (1µg/kg-2 ml) Group T (tramadol group): patients received 20 ml bupivacaine 0.5% plus tramadol (1mg/kg-2 ml)

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Masking Description

Randomization established using the computer-generated closed envelopes method.

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • American Society of Anesthesiologists (ASA) physical status I/II. scheduled for forearm or hand surgery

Exclusion Criteria

  • bleeding disorders
  • patients who got opioid analgesics or monoamine oxidase inhibitors before surgery,
  • history of seizures, respiratory or cardiac diseases
  • local infections at the site where the needle for the block is to be inserted
  • a pregnant woman
  • the block effect was partial and required supplementary anesthesia

Outcomes

Primary Outcomes

Onset time of sensory block in minutes

Time Frame: 40 minutes

After the injection of the solution, every patient was checked for the onset of sensory blockade using goose soaked with iced normal saline by the following scale (three-point scale): Grade 0= perceived as normal sensation, Grade 1 = loss of cold sensation (analgesia), Grade 2= loss of sensation of touch (anesthesia).

onset time of motor blockade in minutes using the modified Bromage scale (Three-point scale)

Time Frame: 40 minutes

the modified Bromage scale (Three-point scale): Grade 0: Normal motor function, Grade 1: Decreased motor strength with the ability to move the fingers only, Grade 2: Complete motor block with an inability to move the fingers.

Duration of sensory block in hours

Time Frame: 24 hours

It's the time from sensory block onset to the time of restoration of sensation at the surgical site

Duration of motor block in hours

Time Frame: 24 hours

It's the time from motor block onset to the restoration of global mobility in the hand and the wrist.

Secondary Outcomes

  • Visual analog scale (VAS): the VAS consisted of a straight, vertical 10-cm line; the bottom point represented "no pain" = (0 cm) and the top "the worst pain you ever have" = (10 cm).(24 hours)
  • Postoperative first analgesic request time in hours(24 hours)
  • Rescue analgesia in the form of 0.05 mg/kg morphine sulfate intravenously(24 hours)
  • Mean blood pressure in mmHg(24 hours)
  • heart rate in beats / minute(24 hours)
  • peripheral oxygen saturation(24 hours)

Investigators

Sponsor
Aswan University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

huda fahmy

Assistant professor of Anesthesia and Intensive Care

Aswan University Hospital

Study Sites (2)

Loading locations...

Similar Trials